STAT+: OpenEvidence raises $250 million, doubling its valuation

Slingshot AI will withdraw its therapy chatbot app Ash from the U.K. over concerns it runs afoul of medical device regulations.

And other health news from Morning Rounds today

FDA cleared an AI tool from Aidoc that can detect multiple conditions from a single CT scan.

Health Canada is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including possibly the U.S. FDA

In this edition of AI Prognosis: An interview with former CEO of health insurer Humana, and health AI news you need to know.

And other biotech news, brought to you by The Readout newsletter

When the U.S. withdrawal from the WHO goes into effect Thursday, the world’s largest economy will be leaving the global health agency with a hefty unpaid bill.

Congressional appropriations committees offered a near-total rebuke of President Trump’s proposed downsizing and reshaping of the NIH.